Notice2021-17353
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 13, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Prevalence Survey of Healthcare- Associated Infections and Antimicrobial Use in U.S. Acute Care Hospitals. This project examines the numbers and types of Healthcare- Associated Infections and causative pathogens, types of antimicrobial drugs (such as antibiotics) used, and the quality of antimicrobial prescribing in U.S. acute care hospitals.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 154 (Friday, August 13, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 154 (Friday, August 13, 2021)]
[Notices]
[Pages 44723-44725]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-17353]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0852; Docket No. CDC-2021-0082]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Prevalence Survey of Healthcare-
Associated Infections and Antimicrobial Use in U.S. Acute Care
Hospitals. This project examines the numbers and types of Healthcare-
Associated Infections and causative pathogens, types of antimicrobial
drugs (such as antibiotics) used, and the quality of antimicrobial
prescribing in U.S. acute care hospitals.
DATES: CDC must receive written comments on or before October 12, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0082 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#650a0807250601064b020a13"><span class="__cf_email__" data-cfemail="a6c9cbc4e6c5c2c588c1c9d0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary
[[Page 44724]]
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 10/31/2022)--Extension--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and improving
antimicrobial use (AU) are both CDC and national priorities. An
essential step in reducing the occurrence of HAIs is to accurately
estimate the burden of these infections in U.S. acute care hospitals
and to describe the types of HAIs and causative pathogens. Periodic
assessments of the magnitude and types of HAIs and AU occurring in all
patient populations within acute care hospitals are needed to inform
decisions by policy makers and hospital infection control personnel
(ICP) regarding appropriate targets and strategies for HAI prevention
and antimicrobial stewardship.
Since 2009, CDC has conducted four prevalence surveys (i.e., pilot
survey in 2009, limited-scale survey in 2010, and two full-scale
surveys in 2011 and 2015) in partnership with the CDC's Emerging
Infections Program (EIP) sites. Findings from the most recent survey
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011. CDC was granted approval from
OMB to conduct a fifth survey in 2020, but due to the COVID-19 pandemic
the survey was postponed to 2023.
Minor adjustments to data collection instruments since the previous
2019 OMB approval have been made. These adjustments were made to
enhance future analyses and utility of the survey data. These changes
are non-substantive and are not expected to increase the public
reporting burden. An extension of the prevalence survey's existing OMB
approval is sought to allow a repeat HAI and AU Prevalence Survey to be
performed in 2023. A repeat survey will allow assessment of changes in
HAI and AU prevalence, pathogen distribution, and quality of
antimicrobial prescribing. These data will also allow CDC and its
partners to continue to monitor HAI and AU trends, to measure progress
in meeting national targets, and to further refine prevention
strategies. In the 2023 survey, data collection will occur within acute
care general hospitals of varying size in each of the 10 EIP sites
(i.e., CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN).
Infection Control Personnel (ICP) in participating hospitals may
assist EIP site personnel in collecting demographic and limited
clinical data from the electronic or paper-based medical records of a
sample of randomly selected patients on a single day in 2023. Patients
will not be interviewed, and no direct interaction with patients will
occur. Hospital and patient-level data will be collected using unique
identification codes. EIP site personnel will submit hospital and
patient-level data to CDC using a secure data management system.
Based on experiences from previous surveys, the time required to
complete the Healthcare Facility Assessment Form (HFA) and Patient
Information Form (PIF) is estimated to be 45 and 17 minutes,
respectively. To conduct the full-scale survey in a three-year approval
period, 100 hospital respondents will complete both the HFA (1x) and
the PIF (on average 63x) per year.
To assess changes in HAIs and AU over time, EIP sites will seek
participation from the same hospitals that participated in prior
surveys. These hospitals were originally selected for participation
using a stratified random sampling scheme based on the number of
staffed acute care beds (i.e., small: <150 staffed beds; medium: 151-
399 staffed beds; large: >400 staffed beds). Each site will also have
the option to recruit additional hospitals for a total of up to 30 in
each site. As in previous surveys, hospital participation will remain
voluntary. Within each participating hospital, EIP site personnel will
establish patient sample size targets based on the number of staffed
acute care beds (e.g., up to 75 patients in small hospitals, 75
patients in medium hospitals, and 100 patients in large hospitals).
The total estimated annualized public burden is 1,860 hours, which
represents no change from the 2019 OMB approval. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (i.e., Healthcare 100 1 45/60 75
Infection Preventionist). Facility
Assessment.
Patient 100 63 17/60 1,785
Information
Form.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,860
----------------------------------------------------------------------------------------------------------------
[[Page 44725]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-17353 Filed 8-12-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 13, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.